Genmab A (GMAB) Shares Outstanding (Diluted Average) (2018 - 2026)

Genmab A has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $0.83 in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) fell 94.6% year-over-year to $0.83; the trailing twelve-month figure through Mar 2026 stood at $0.83 (down 94.6% YoY), and the FY2025 full-year result was $15.37, down 12.72% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $0.83, down from $14.9 in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $17.61 in Q1 2024, with the low at $0.83 in Q1 2026.
• Historically, Shares Outstanding (Diluted Average) has averaged $12.54 across 3 years, with a median of $15.14 in 2025.
• Annual changes were most pronounced in 2025 — Shares Outstanding (Diluted Average) jumped 65.74% — and 2026, when it slumped 94.6%.
• Genmab A's Shares Outstanding (Diluted Average) stood at $17.53 in 2024, then slipped by 15.0% to $14.9 in 2025, then slumped by 94.43% to $0.83 in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $0.83 (Q1 2026), $14.9 (Q3 2025), and $15.37 (Q1 2025), per Business Quant data.